What MDLifespan does

MDLifespan (legal entity MDLifespan Enterprises LLC), founded in June 2023 and headquartered in Chicago, Illinois, is a physician-led, Public Benefit Corporation that operates a preventive longevity platform built around its patent-pending PlasmaXchange™ (Advanced Serial Therapeutic Plasma Exchange) protocols. Using FDA-approved apheresis machines, the company exchanges 1,500–3,000 mL of plasma per session (versus the standard ~500 mL plasma donation) with a saline-albumin-vitamin replacement solution, packaging this core procedure into eight specialized protocols (MDL Mold, MDL Toxin, MDL Brain, MDL Heart, MDL Cancer, MDL Longevity, MDL Immunity, MDL Baby) aimed at reducing circulating environmental toxins, including PFAS, microplastics, pesticides, and heavy metals. The service is supplemented by a proprietary diagnostic suite (Toxin Test & Talk, plus Aging, Alzheimer's, Cancer, Heart, Immune, Baby, and Neurotransmitter panels) and adjacent services spanning bioidentical hormone replacement, peptide therapy, genetic and telomere analysis, and stem cell therapy.

Revenue is generated primarily through fee-for-service TPE sessions sold as multi-session protocol packages, with financing offered at 50% upfront and the balance split across three payments over 90 days. Distribution is hybrid: a company-owned Chicago clinic delivers direct-to-consumer services, complemented by clinical partnerships — most prominently a January 2026 strategic alliance with Cenegenics that deploys MDLifespan's protocols across the partner's U.S. age-management network (with announced launches in Beverly Hills, Miami, and Atlanta) and independent-physician locations such as Dr. Christopher Davis in Sarasota, Florida.

Acquisition channels combine D2C free-consultation funnels, physician-led national webinars, educational events, paid and earned media (Bloomberg, The New York Times, Goop, Fox News, Newsweek, Dr. Will Cole podcast), a company podcast ('TPE Blueprint'), free guidebooks, the founder's 'Avoiding Toxins' book (March 2025), and a generative-AI chatbot feature ('Ask AI Dr. Savage'). Leadership is concentrated around founder and CMO Dr. Paul Savage, with CGO and Chief Education Officer Dr. Pamela W. Smith, co-founder Dr. Edwin Lee, and a credentialed clinical team; the company discloses no institutional funding rounds and operates with 11–50 employees.

Name

MDLifespan

Legal name

MDLifespan Enterprises LLC

Website

https://mdlifespan.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

MDLifespan is a physician-led Chicago-based longevity company that runs patent-pending PlasmaXchange therapeutic plasma exchange protocols via its own clinic and clinical partnerships (including Cenegenics), targeting health-conscious adults seeking environmental toxin removal and biomarker-driven health optimization.

Ownership category

akta.pro rank

Product category

Longevity Medicine

NAICS

Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (62151)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Plasma-Derived Therapy Quality, Safety & Pharmacovigilance (Pathogen Reduction/Testing) (HLAIAHAK)

Keywords

• Therapeutic plasma exchange
• Toxin removal services
• Longevity medicine
• Biomarker diagnostic panels
• Regenerative health services

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Therapeutic Plasma Exchange Sessions: MDLifespan generates revenue primarily through fee-for-service TPE sessions. Services are offered as multi-session protocol packages (e.g., MDL Brain, MDL Toxin, MDL Longevity) tailored to specific health goals. Financing is available: patients pay 50% upfront and the remaining amount is split into 3 payments over 90 days.
2. Diagnostic Testing Services: The company offers comprehensive test panels including Aging Panel, Alzheimer's Panel, Baby Panel, Cancer Panel, Heart Panel, Immune Panel, Neurotransmitter Panel, and Toxin Test & Talk for biomarker tracking and toxin burden assessment.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

MDLifespan offers physician-led Advanced Serial Therapeutic Plasma Exchange (PlasmaXchange) protocols that physically remove circulating environmental toxins, including PFAS, microplastics, heavy metals, and pesticides, from the bloodstream. The company provides eight specialized protocol packages (MDL Mold, MDL Toxin, MDL Brain, MDL Heart, MDL Cancer, MDL Longevity, MDL Immunity, MDL Baby) tailored to specific health goals, complemented by comprehensive diagnostic test panels and adjacent regenerative services such as bioidentical hormone therapy, peptide therapy, genetic and telomere analysis, and stem cell therapy.

Product overview

MDLifespan is a physician-led medical technology company and Public Benefit Corporation offering a platform-based product architecture centered on its patent-pending PlasmaXchange (Advanced Serial Therapeutic Plasma Exchange) protocols. The core PlasmaXchange service is a minimally invasive therapeutic procedure that filters toxins from the bloodstream, supported by eight specialized protocol modules: MDL Mold, MDL Toxin, MDL Brain, MDL Heart, MDL Cancer, MDL Longevity, MDL Immunity, and MDL Baby—each targeting specific health concerns. Complementing the TPE platform is a suite of diagnostic services including Total Toxin Testing, Toxin Test & Talk consultations, and specialized test panels (Aging, Alzheimer's, Baby, Cancer, Disease, Heart, Immune, and Neurotransmitter). The company also offers AI-powered conversational support through 'Ask AI Dr. Savage,' along with adjacent services including bioidentical hormone therapy, peptide therapy, genetic/telomere analysis, and stem cell therapy. Educational resources include the 'Avoiding Toxins' book and MDL Clean Guidebook. MDLifespan operates through clinical partnerships with established physician-led clinics including Cenegenics locations and independent practitioners.

Differentiator

Problem solved

Functional benefit

Brands

• PlasmaXchange: Proprietary patent-pending Therapeutic Plasma Exchange protocols designed to remove toxins from the body. Includes specialized protocols such as MDL Mold, MDL Toxin, MDL Brain, MDL Heart, MDL Cancer, MDL Longevity, MDL Immunity, and MDL Baby.

Products and services

• PlasmaXchange (Advanced Serial Therapeutic Plasma Exchange) MDLifespan's primary therapeutic offering using patent-pending Advanced Serial Therapeutic Plasma Exchange (TPE) protocols. A minimally invasive, physician-supervised procedure that removes circulating toxins, inflammatory proteins, and environmental contaminants from the bloodstream by exchanging plasma with a specialized saline-albumin-vitamin solution.
• MDL Mold Protocol Specialized PlasmaXchange protocol targeting mold exposure and biotoxin accumulation, designed to detoxify, heal, and strengthen individuals affected by mold-related health issues.
• MDL Toxin Protocol PlasmaXchange protocol focused on reducing overall toxic burden from environmental toxins, pesticides, heavy metals, and industrial chemicals.
• MDL Brain Protocol
• MDL Heart Protocol
• MDL Cancer Protocol
• MDL Longevity Protocol
• MDL Immunity Protocol
• MDL Baby Protocol
• MDL TPE 1 (MDL Basic)
• Toxin Test & Talk
• Test Panels
• Bioidentical Hormone Therapy
• Peptide Therapy
• Genetic and Telomere Analysis
• Stem Cell Therapy
• Book: Avoiding Toxins

Quantifiable outcome

• Over 300% performance improvement vs standard TPE
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core, regional and minor.

• CenegenicscoreStrategic or Co-development Partner · 22 January 2026MDLifespan partnered with Cenegenics (global leader in age-management medicine) to expand Therapeutic Plasma Exchange across the United States. Cenegenics integrates MDLifespan's PlasmaXchange protocols across its centers to address environmental toxins and inflammation. Initial service locations include Beverly Hills, Miami, and Atlanta.
• Dr. Christopher DavisregionalStrategic or Co-development Partner · 3 November 2025MDLifespan expanded to Sarasota, Florida partnering with Dr. Christopher Davis to establish a PlasmaXchange location focused on toxin removal and detoxification, particularly targeting environmental toxins and mold exposure. The humid Florida climate drives demand for detox treatments.
• 4OceanminorGTM or Marketing PartnerEnvironmental cleanup partnership with 4Ocean, an ocean cleanup organization. Supports MDLifespan's brand positioning around environmental toxin awareness and reduction.

Scale indicators3 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Next Health: Membership-based longevity and performance clinic offering IV therapy, hormone optimization, diagnostics, and aesthetic services. Directly comparable consumer-facing wellness model targeting affluent health-optimization consumers.
• Fountain Life: Premium preventive health and longevity platform combining advanced diagnostics, AI-driven imaging, and clinician-led programs. Overlaps with MDLifespan in biomarker tracking, longevity focus, and affluent consumer base.
• Restore Hyper Wellness: National retail wellness clinic chain offering IV drips, cryotherapy, hormone optimization, and diagnostics. Comparable outpatient consumer wellness model with multi-location expansion strategy.
• Remedy Place: Social wellness club offering IV therapy, cryotherapy, infrared sauna, and longevity-adjacent experiences. Comparable retail consumer wellness model and luxury demographic.

Broad incumbents

• Cenegenics: Established age-management medicine network and MDLifespan's largest channel partner. Comparable patient demographic (executives, longevity seekers) and physician-led model, with a broader preventive medicine portfolio.

Emerging players

• InsideTracker: Personalized blood-based biomarker and longevity testing platform with action plans. Comparable diagnostic-led approach but software/DTC rather than procedural services.
• Function Health: Membership-based comprehensive lab testing and longevity diagnostics platform. Comparable focus on biomarker-driven health optimization for consumer audiences, though without procedural services.
• Parsley Health: Functional medicine membership platform combining diagnostics, physician consultations, and personalized care plans. Comparable holistic longevity positioning with a stronger telehealth model.
• Marek Health: Telehealth platform for hormone optimization, peptide therapy, and longevity-focused treatment. Comparable adjacent services (hormones, peptides) and similar affluent male-skewing longevity audience.

Others

• Elysium Health: Science-driven longevity supplement and consumer health company targeting the same demographic interested in cellular health and aging. Comparable longevity brand narrative though product rather than service-led.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MDLifespan
• Facebookfacebook.com/MDLifespan
• LinkedInlinkedin.com/company/mdlifespan

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MDLifespan